Rodrigo Paredes de la Fuente

6PUBLICATIONS
13CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 20, 2026
Evolving Trends in Latin American Participation in Global Oncology Clinical Trials: A Decade of Phase III Activity (2013-2022).

Rodrigo Paredes de la Fuente, Alexander B Karol, Anneliese Markus

|Sep 26, 2025
Documentation of patient withdrawals, retention strategies, and postwithdrawal data practices in cancer clinical trials.

Alexander B Karol, Rodrigo Paredes, Anna Argulian

|Aug 05, 2025
Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of KEAP1, SMARCA4, and PTEN mutations.

Rodrigo Paredes, Roberto Borea, Francesco Drago

|Jul 10, 2025
Prognostic Role of MTAP Loss in Cholangiocarcinoma.

James Lyon, Soravis Osataphan, Vaibhav Birda

|Aug 10, 2024
Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel.

Rodrigo Paredes de la Fuente, Santiago Sucre, Cristina Ponce

|Feb 06, 2023
Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumab.

Rodrigo Paredes de la Fuente, James W Doolin, Mary Linton Peters

Pageof 1

Frequent Collaborators

3 joint publications

Mary Linton Peters

2 joint publications

Alexander B Karol

2 joint publications

Himanshu Joshi

2 joint publications

Yu Fujiwara